CG Oncology (CGON) Current Leases (2023 - 2026)

CG Oncology (CGON) has 4 years of Current Leases data on file, last reported at $1.1 million in Q1 2026.

• Quarterly Current Leases rose 318.04% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 318.04% YoY) and the FY2025 annual result came in at $915000.0, up 391.94% from the prior year.
• Current Leases climbed to $1.1 million in Q1 2026, from $915000.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $1.1 million in Q1 2026 to a low of $186000.0 in Q4 2024.
• A 4-year average of $452100.0 and a median of $246000.0 in 2024 frame the typical range for Current Leases.
• Annual changes were most pronounced in 2024 — Current Leases retreated 14.29% — and 2025, when it soared 391.94%.
• Tracing CGON's Current Leases over 4 years: stood at $217000.0 in 2023, then decreased by 14.29% to $186000.0 in 2024, then soared by 391.94% to $915000.0 in 2025, then rose by 16.5% to $1.1 million in 2026.
• The last three Current Leases figures came in at $1.1 million (Q1 2026), $915000.0 (Q4 2025), and $912000.0 (Q3 2025), per Business Quant data.